Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis

Author: Staflin Karin   Krueger Joseph   Hachmann Janna   Forsyth Jane   Lorger Mihaela   Steiniger Sebastian   Mee Jenny   Pop Cristina   Salvesen Guy   Janda Kim   Felding-Habermann Brunhilde  

Publisher: Springer Publishing Company

ISSN: 0262-0898

Source: Clinical and Experimental Metastasis, Vol.27, Iss.4, 2010-04, pp. : 217-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content